Search research articles
Contact Us
Filters
Showing results (41-50 of 57) with videos related to
Page
of 6
Sort By:
Journal of Clinical Microbiology
|
February 18, 2011
New Delhi metallo-β-lactamase (NDM-1)-producing Klebsiella pneumoniae: case report and laboratory detection strategies
A Brian Mochon, Omai B Garner, Janet A Hindler, et al.
AIDS (London, England)
|
April 8, 2015
Incomplete immune reconstitution despite virologic suppression in HIV-1 infected children and adolescents
Paul Krogstad, Kunjal Patel, Brad Karalius, et al.
The New England Journal of Medicine
|
June 11, 2020
Disseminated Coccidioidomycosis Treated with Interferon-γ and Dupilumab
Monica Tsai, Timothy J Thauland, Alden Y Huang, et al.
AIDS (London, England)
|
January 6, 2016
Supranormal thymic output up to 2 decades after HIV-1 infection
Christian R Aguilera-Sandoval, Otto O Yang, Nebojsa Jojic, et al.
Frontiers in Immunology
|
March 11, 2022
Dominant CD8<sup>+</sup> T Cell Nucleocapsid Targeting in SARS-CoV-2 Infection and Broad Spike Targeting From Vaccination
Ellie Taus, Christian Hofmann, Francisco Javier Ibarrondo, et al.
Transplantation
|
March 24, 2005
Infectious enteritis after intestinal transplantation: incidence, timing, and outcome
David Ziring, Robert Tran, Susan Edelstein, et al.
Journal of Virology
|
November 25, 2005
Genetic and stochastic influences on the interaction of human immunodeficiency virus type 1 and cytotoxic T lymphocytes in identical twins
Otto O Yang, Joseph Church, Christina M R Kitchen, et al.
AIDS (London, England)
|
November 6, 2019
Pharmacokinetics and safety of a raltegravir-containing regimen in HIV-infected children aged 2-12 years on rifampicin for tuberculosis
Tammy Meyers, Pearl Samson, Edward P Acosta, et al.
Frontiers in Immunology
|
March 2, 2023
Persistent memory despite rapid contraction of circulating T Cell responses to SARS-CoV-2 mRNA vaccination
Ellie Taus, Christian Hofmann, F Javier Ibarrondo, et al.
Journal of the Pediatric Infectious Diseases Society
|
May 26, 2020
Pharmacokinetics and Safety of a Raltegravir-Containing Regimen in Children Aged 4 Weeks to 2 Years Living With Human Immunodeficiency Virus and Receiving Rifampin for Tuberculosis
Paul Krogstad, Pearl Samson, Edward P Acosta, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 57) with videos related to
Sort By:
Page
of 6
Journal of Clinical Microbiology
|
February 18, 2011
New Delhi metallo-β-lactamase (NDM-1)-producing Klebsiella pneumoniae: case report and laboratory detection strategies
A Brian Mochon, Omai B Garner, Janet A Hindler, et al.
AIDS (London, England)
|
April 8, 2015
Incomplete immune reconstitution despite virologic suppression in HIV-1 infected children and adolescents
Paul Krogstad, Kunjal Patel, Brad Karalius, et al.
The New England Journal of Medicine
|
June 11, 2020
Disseminated Coccidioidomycosis Treated with Interferon-γ and Dupilumab
Monica Tsai, Timothy J Thauland, Alden Y Huang, et al.
AIDS (London, England)
|
January 6, 2016
Supranormal thymic output up to 2 decades after HIV-1 infection
Christian R Aguilera-Sandoval, Otto O Yang, Nebojsa Jojic, et al.
Frontiers in Immunology
|
March 11, 2022
Dominant CD8<sup>+</sup> T Cell Nucleocapsid Targeting in SARS-CoV-2 Infection and Broad Spike Targeting From Vaccination
Ellie Taus, Christian Hofmann, Francisco Javier Ibarrondo, et al.
Transplantation
|
March 24, 2005
Infectious enteritis after intestinal transplantation: incidence, timing, and outcome
David Ziring, Robert Tran, Susan Edelstein, et al.
Journal of Virology
|
November 25, 2005
Genetic and stochastic influences on the interaction of human immunodeficiency virus type 1 and cytotoxic T lymphocytes in identical twins
Otto O Yang, Joseph Church, Christina M R Kitchen, et al.
AIDS (London, England)
|
November 6, 2019
Pharmacokinetics and safety of a raltegravir-containing regimen in HIV-infected children aged 2-12 years on rifampicin for tuberculosis
Tammy Meyers, Pearl Samson, Edward P Acosta, et al.
Frontiers in Immunology
|
March 2, 2023
Persistent memory despite rapid contraction of circulating T Cell responses to SARS-CoV-2 mRNA vaccination
Ellie Taus, Christian Hofmann, F Javier Ibarrondo, et al.
Journal of the Pediatric Infectious Diseases Society
|
May 26, 2020
Pharmacokinetics and Safety of a Raltegravir-Containing Regimen in Children Aged 4 Weeks to 2 Years Living With Human Immunodeficiency Virus and Receiving Rifampin for Tuberculosis
Paul Krogstad, Pearl Samson, Edward P Acosta, et al.
Page
of 6